Organon & Co. (OGN) Earnings Date, Estimates & Call Transcripts $21.02 -0.01 (-0.05%) (As of 09:34 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateNov. 7EstimatedActual EPS (Aug. 6) $1.12 Beat By $0.04 Consensus EPS (Aug. 6) $1.08 Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide DeckSEC 10-Q/10-K Filing Get Organon & Co. Earnings AlertsEnter your email address below to receive the latest news and earnings results for OGN and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueOGN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.OGN Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaThis Crypto Is Set to Explode in AugustWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make HUGE gains. Industry Giants are Investing Heavily in Blockchain Technology and THIS COIN is at the Heart of Their Strategy. It's a groundbreaking opportunity that could be poised for extraordinary gains. Go here to get full details on this crypto now. Organon & Co. Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:$4.14 EPSNext Year EPS Consensus Estimate: $4.19 EPSOGN Earnings Date and InformationOrganon & Co. last announced its quarterly earnings data on August 6th, 2024. The reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $0.04. The business had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.61 billion. Its quarterly revenue was down .1% on a year-over-year basis. Organon & Co. has generated $4.09 earnings per share over the last year ($4.09 diluted earnings per share) and currently has a price-to-earnings ratio of 5.1. Earnings for Organon & Co. are expected to grow by 1.21% in the coming year, from $4.14 to $4.19 per share. Organon & Co. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off prior year's report dates.Read More Organon & Co. Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/7/2024(Estimated)------- 8/6/2024Q2 2024$1.08$1.12+$0.04$1.31$1.61 billion$1.61 billion 5/2/2024Q1 2024$0.83$1.14+$0.31$1.50$1.57 billion$1.62 billion 2/15/2024Q4 2023$0.73$0.87+$0.14($0.39)$1.55 billion$1.60 billion 11/2/2023Q3 2023$1.04$0.78($0.26)$1.33$1.59 billion$1.52 billion 8/8/2023Q2 2023$0.97$1.31+$0.34$1.67$1.57 billion$1.61 billion 5/4/2023Q1 2023$1.18$1.08($0.10)$1.47$1.54 billion$1.54 billion Get the Latest News and Ratings for OGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Organon & Co. and its competitors with MarketBeat's FREE daily newsletter. 2/16/2023Q4 2022$0.85$0.81($0.04)$1.20$1.50 billion$1.49 billion 11/3/2022Q3 2022$1.12$1.32+$0.20$1.75$1.49 billion$1.54 billion 8/4/2022Q2 2022$1.16$1.25+$0.09$1.58$1.50 billion$1.59 billion 5/5/2022Q1 2022$1.31$1.65+$0.34$1.94$1.52 billion$1.57 billion 2/17/2022Q4 2021$1.25$1.37+$0.12$1.95$1.58 billion$1.60 billion 11/11/2021Q3 2021$1.44$1.67+$0.23$2.07$1.59 billion$1.60 billion 8/12/2021Q2 2021$1.49$1.72+$0.23$1.76$1.54 billion$1.60 billion 6/20/2021Q1$1.5150$1.58+$0.0650$1.54$1.58 billion$1.51 billion Organon & Co. Earnings - Frequently Asked Questions When is Organon & Co.'s earnings date? Organon & Co. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates. Learn more on OGN's earnings history. What guidance has Organon & Co. issued on next quarter's earnings? Organon & Co. issued an update on its FY 2024 earnings guidance on Tuesday, August, 6th. The company issued revenue guidance of $6.3 billion-$6.5 billion, compared to the consensus revenue estimate of $6.4 billion. Did Organon & Co. beat their earnings estimates last quarter? In the previous quarter, Organon & Co. (NYSE:OGN) reported $1.12 earnings per share (EPS) to beat the analysts' consensus estimate of $1.08 by $0.04. Learn more on analysts' earnings estimate vs. OGN's actual earnings. How can I listen to Organon & Co.'s earnings conference call? The conference call for Organon & Co.'s latest earnings report can be listened to online. Listen to Conference Call How can I read Organon & Co.'s conference call transcript? The conference call transcript for Organon & Co.'s latest earnings report can be read online. Read Transcript How can I view Organon & Co.'s earnings report? Organon & Co.'s earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Organon & Co. generate each year? Organon & Co. (NYSE:OGN) has a recorded annual revenue of $6.26 billion. How much profit does Organon & Co. generate each year? Organon & Co. (NYSE:OGN) has a recorded net income of $1.02 billion. OGN has generated $4.09 earnings per share over the last four quarters. What is Organon & Co.'s price-to-earnings ratio? Organon & Co. (NYSE:OGN) has a trailing price-to-earnings ratio of 5.14 and a forward price-to-earnings ratio of 5.08. The price/earnings-to-growth ratio is 0.88. What is Organon & Co.'s EPS forecast for next year? Organon & Co.'s earnings are expected to grow from $4.14 per share to $4.19 per share in the next year, which is a 1.21% increase. More Earnings Resources from MarketBeat Related Companies: BioNTech Earnings Date Teva Pharmaceutical Industries Earnings Date BeiGene Earnings Date Genmab A/S Earnings Date Dr. Reddy's Laboratories Earnings Date Viatris Earnings Date Sarepta Therapeutics Earnings Date Catalent Earnings Date Qiagen Earnings Date Legend Biotech Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Target Hits the Mark: Q2 Earnings Exceed ExpectationsModerna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?Doximity: The 'Facebook for Doctors' Surges After Earnings BeatDeere Rebounds on Earnings Beat, But Uphill Battle RemainsWhy You Shouldn't Count Out Tencent Music Stock After EarningsHut 8 Corp.’s Earnings: Is Crypto Mining About to Change?Is NVIDIA Stock a Buy Ahead of Earnings? This page (NYSE:OGN) was last updated on 8/22/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could becom...DTI | SponsoredUS developing “superweapon” to defeat China and Russia?Our new superweapon is a gift to every patriot. I predict the devastating new tech behind this weapon will cre...Paradigm Press | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredAmazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | Sponsored625,000% GainThe recent crypto pullback has been brutal, causing widespread panic among investors. But for us, it’s just an...Crypto Swap Profits | SponsoredThe #1 A.I. Crypto You Don’t Own (YET!)Markets are volatile right now—stocks, cryptos, you name it. But here's a crucial fact everyone is missing:...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organon & Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organon & Co. With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.